Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307339/
https://www.ncbi.nlm.nih.gov/pubmed/37387756
http://dx.doi.org/10.1155/2023/9807108
_version_ 1785066024056389632
author Markers, Disease
author_facet Markers, Disease
author_sort Markers, Disease
collection PubMed
description
format Online
Article
Text
id pubmed-10307339
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103073392023-06-29 Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function Markers, Disease Dis Markers Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307339/ /pubmed/37387756 http://dx.doi.org/10.1155/2023/9807108 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Markers, Disease
Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
title Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
title_full Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
title_fullStr Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
title_full_unstemmed Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
title_short Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
title_sort retracted: efficacy of dapagliflozin in patients with diabetes mellitus complicated with coronary artery disease and its impact on the vascular endothelial function
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307339/
https://www.ncbi.nlm.nih.gov/pubmed/37387756
http://dx.doi.org/10.1155/2023/9807108
work_keys_str_mv AT markersdisease retractedefficacyofdapagliflozininpatientswithdiabetesmellituscomplicatedwithcoronaryarterydiseaseanditsimpactonthevascularendothelialfunction

Ejemplares similares